Treatment(s) now being considered-Chemotherapy - Page 6 of 16 Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Chemotherapy Posts on Medivizor

Can white blood cell count ratios help predict outcomes for newly diagnosed HL patients receiving PET2-mediated treatment?

Can white blood cell count ratios help predict outcomes for newly diagnosed HL patients receiving PET2-mediated treatment?

Posted by on Apr 6, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the impact of white blood cell counts on the outcomes of newly diagnosed Hodgkin’s lymphoma (HL) patients receiving treatment mediated by PET2 (PET scanning after 2 cycles of chemotherapy). This study concluded that ratios of different types of white blood cells combined with PET2 can be a meaningful...

Read More

Does PET/CT scanning after one ABVD cycle better predict treatment outcomes than scanning after two cycles (iPET2)?

Does PET/CT scanning after one ABVD cycle better predict treatment outcomes than scanning after two cycles (iPET2)?

Posted by on Feb 20, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study analyzed PET/CT scans from new Hodgkin’s lymphoma patients after one (iPET1) or two (iPET2) cycles of ABVD chemotherapy. The study concluded that iPET2 is better than iPET1 at predicting ABVD outcomes in HL patients. Some background Interem PET/CT scanning is used to guide early treatment for new Hodgkin’s...

Read More

What are the outcomes for early-stage HL patients treated with ABVD and radiotherapy alone?

What are the outcomes for early-stage HL patients treated with ABVD and radiotherapy alone?

Posted by on Jan 16, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study determined the outcomes of early-stage classical Hodgkin’s lymphoma (HL) patients who received ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) chemotherapy and radiotherapy (RT) only. The study concluded that patients who showed a good partial response (tumor shrinkage) to ABVD chemotherapy were successfully...

Read More

How safe and effective is combined brentuximab vedotin and bendamustine in patients with relapsed/refractory HL?

How safe and effective is combined brentuximab vedotin and bendamustine in patients with relapsed/refractory HL?

Posted by on Jan 6, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study determined the safety and effectiveness of combined brentuximab vedotin (Adcetris) and bendamustine (Treanda) for relapsed or refractory (did not respond to treatment) Hodgkin’s lymphoma (HL). The study concluded that this combination is safe and effective, even for patients who already received intense anticancer...

Read More

FOLFOXIRI is associated with improved treatment outcomes in metastatic colorectal cancer patients

FOLFOXIRI  is associated with improved treatment outcomes in metastatic colorectal cancer patients

Posted by on Dec 30, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of the chemotherapy FOLFOXIRI as treatment for colorectal cancer. Researchers suggested that this chemotherapy is associated with improved treatment outcomes. Some background Chemotherapy is used in cancer patients to reduce symptoms and prolong survival. Chemotherapy drugs attack cancer...

Read More

Post-surgery complications can affect chemotherapy treatment after surgery in colorectal cancer

Posted by on Sep 28, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the post-surgery factors that affect the use of chemotherapy after surgery in colorectal cancer patients. Researchers suggested that post-surgery complications are associated with delay or not receiving chemotherapy treatment.   Some background Surgery and post-surgery chemotherapy are the standard...

Read More

A review of chemotherapy alone or chemotherapy plus radiation therapy to treat adult patients with Hodgkin lymphoma

A review of chemotherapy alone or chemotherapy plus radiation therapy to treat adult patients with Hodgkin lymphoma

Posted by on Sep 26, 2017 in Hodgkin's lymphoma | 0 comments

In a nutshell This paper is a review of the effectiveness of chemotherapy alone or chemotherapy plus radiotherapy for treating adult patients with early stage Hodgkin lymphoma. The review concluded that, for the same chemotherapy regimen, RT may increase progression free survival, but has little effect on overall survival for patients. Some background...

Read More

How safe and effective is chemotherapy given through the limb in elderly melanoma patients?

How safe and effective is chemotherapy given through the limb in elderly melanoma patients?

Posted by on Sep 13, 2017 in Melanoma | 0 comments

In a nutshell This study looked at the safety and effectiveness of isolated limb infusion in elderly patients with melanoma of the skin on a limb (arm/leg) that could not be surgically removed. The study found isolated limb infusion to be safe and effective in elderly patients.  Some background lsolated limb perfusion (ILP) is a method of...

Read More